London, UK; Brentwood, TN, US; 27 April 2007 - Protherics PLC ("Protherics" or
the "Company"), the international biopharmaceutical company focused on critical
care and cancer, announces that the following notification of interest in the
ordinary share capital of the Company was received on 26 April 2007 from Aviva
plc.
